Home
Data
Calendar
Blog
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | NA | NA | 0.00 | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 68.43 | NA | 49.21 | 49.06 | 49.03 | NA | 48.92 | 48.82 | 48.73 | NA | 48.49 | 43.86 | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 68.43 | NA | 49.21 | 49.06 | 49.03 | NA | 48.92 | 48.82 | 48.73 | NA | 48.49 | 43.86 | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic | -0.41 | -0.68 | -0.55 | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 | -0.65 | -0.31 | -0.51 | -0.51 | -0.49 | 304.19 | -148.01 | -78.26 | -80.88 | -71.18 | -75.31 | |
| Earnings Per Share Diluted | -0.41 | -0.68 | -0.55 | -0.73 | -0.71 | -0.76 | -0.65 | -0.56 | -0.65 | -0.31 | -0.51 | -0.51 | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 3.04 | 3.26 | 11.07 | 2.66 | 3.76 | 2.85 | 6.75 | 13.83 | 7.65 | 20.08 | 8.50 | 9.78 | 7.43 | 8.26 | 8.45 | 9.67 | 6.82 | 8.21 | 5.36 | |
| Revenues | 3.04 | 3.26 | 11.07 | 2.66 | 3.76 | 2.85 | 6.75 | 13.83 | 7.65 | 20.08 | 8.50 | 9.78 | 7.43 | 8.26 | 8.45 | 9.67 | 6.82 | 8.21 | 5.36 | |
| Operating Expenses | 35.26 | 40.69 | 38.88 | 40.23 | 39.99 | 41.15 | 39.24 | 41.22 | 39.02 | 35.33 | 32.75 | 31.90 | 27.93 | 27.16 | 26.80 | 20.53 | 19.15 | 18.71 | 15.37 | |
| Research And Development Expense | 22.53 | 30.39 | 28.35 | 29.93 | 29.04 | 30.65 | 29.66 | 31.32 | 26.20 | 26.55 | 24.30 | 23.29 | 20.53 | 20.43 | 23.93 | 17.76 | 16.31 | 16.02 | 12.95 | |
| General And Administrative Expense | 10.29 | 10.30 | 10.53 | 10.31 | 10.95 | 10.49 | 9.58 | 9.89 | 12.82 | 8.78 | 8.45 | 8.61 | 7.41 | 6.73 | 2.86 | 2.77 | 2.84 | 2.69 | 2.42 | |
| Operating Income Loss | -32.22 | -37.43 | -27.81 | -37.57 | -36.23 | -38.29 | -32.49 | -27.38 | -31.37 | -15.26 | -24.25 | -22.12 | -20.51 | -18.90 | -18.35 | -10.86 | -12.34 | -10.50 | -10.00 | |
| Interest Paid Net | NA | 0.00 | 0.14 | 0.42 | 0.43 | 0.42 | 0.38 | 0.35 | 0.47 | 0.24 | 0.36 | 0.35 | 0.36 | 0.36 | 0.36 | NA | NA | NA | NA | |
| Gains Losses On Extinguishment Of Debt | NA | 0.00 | -0.62 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Allocated Share Based Compensation Expense | 6.21 | 6.36 | 8.20 | 6.42 | 6.25 | 6.92 | 6.01 | 8.15 | 8.94 | 6.35 | 6.09 | 5.23 | 3.85 | 2.72 | 0.44 | 0.16 | 0.12 | 0.73 | 0.63 | |
| Income Tax Expense Benefit | NA | 0.28 | 1.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | -0.12 | -0.17 | -0.17 | NA | -0.10 | 0.65 | |
| Income Taxes Paid | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Profit Loss | -28.36 | NA | -27.04 | -35.92 | -34.78 | NA | -31.96 | -27.41 | -31.62 | -15.66 | -24.68 | -22.58 | -20.97 | -21.80 | -21.84 | -10.79 | -11.91 | -10.02 | NA | |
| Net Income Loss | -28.36 | -34.75 | -27.04 | -35.92 | -34.78 | -37.19 | -31.96 | -27.41 | -31.62 | -15.66 | -24.68 | -22.58 | -20.97 | -21.80 | -21.84 | -10.79 | -11.91 | -10.02 | -10.09 | |
| Comprehensive Income Net Of Tax | -28.61 | -33.98 | -26.17 | -35.23 | -33.11 | -35.91 | -32.79 | -28.34 | -34.49 | -16.28 | -24.77 | -22.55 | -21.08 | -21.79 | -21.84 | -10.79 | -11.91 | -10.02 | -10.09 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 398.37 | 376.45 | 333.01 | 375.01 | 396.04 | 430.84 | 461.44 | 492.48 | 515.49 | 506.76 | 507.91 | 528.42 | 374.01 | 400.14 | 229.13 | NA | NA | 118.26 | NA | |
| Liabilities | 140.09 | 130.34 | 116.99 | 141.30 | 133.57 | 141.61 | 143.26 | 147.88 | 150.96 | 117.16 | 109.13 | 111.99 | 110.30 | 119.35 | 128.53 | NA | NA | 119.23 | NA | |
| Liabilities And Stockholders Equity | 398.37 | 376.45 | 333.01 | 375.01 | 396.04 | 430.84 | 461.44 | 492.48 | 515.49 | 506.76 | 507.91 | 528.42 | 374.01 | 400.14 | 229.13 | NA | NA | 118.26 | NA | |
| Stockholders Equity | 258.28 | 246.11 | 216.02 | 233.71 | 262.47 | 289.23 | 318.18 | 344.59 | 364.53 | 389.61 | 398.78 | 416.43 | 263.70 | 280.79 | -155.92 | -135.06 | -124.53 | -111.96 | -102.67 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 279.59 | 271.19 | 223.69 | 274.39 | 278.45 | 287.56 | 325.46 | 318.37 | 302.95 | 325.69 | 412.29 | 477.56 | 322.01 | 381.01 | 208.92 | NA | NA | 96.77 | NA | |
| Cash And Cash Equivalents At Carrying Value | 89.66 | 126.59 | 60.97 | 44.88 | 49.48 | 29.75 | 49.55 | 57.30 | 46.00 | 76.12 | 162.75 | 281.15 | 94.91 | 181.73 | 63.43 | 107.65 | 73.86 | 90.55 | 100.97 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 93.10 | 130.03 | 64.42 | 48.16 | 52.76 | 33.03 | 52.83 | 60.58 | 49.28 | 79.40 | 164.02 | 282.42 | 97.49 | 184.30 | 66.01 | 110.23 | 76.43 | 93.13 | 103.55 | |
| Accounts Receivable Net Current | 13.60 | 11.80 | 0.50 | 1.03 | 0.53 | 1.47 | 1.49 | 1.71 | 1.77 | 5.72 | 4.84 | 6.21 | 3.66 | 4.48 | 4.14 | NA | NA | 4.62 | NA | |
| Receivables Net Current | 13.60 | 11.80 | 0.50 | 1.03 | 0.53 | 1.47 | 1.49 | 1.71 | 1.77 | 5.72 | 4.84 | 6.21 | 3.66 | 4.48 | 4.14 | NA | NA | 4.62 | NA | |
| Prepaid Expense And Other Assets Current | 7.80 | 5.71 | 6.62 | 6.07 | 7.60 | 9.93 | 10.31 | 8.88 | 10.00 | 10.69 | 5.38 | 5.44 | 4.88 | 4.84 | 5.37 | NA | NA | 1.59 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 14.89 | 14.89 | 15.19 | 15.36 | 16.22 | 15.52 | 15.09 | 13.77 | 10.19 | 10.02 | 10.12 | 10.12 | 10.10 | 8.96 | 8.79 | NA | NA | 8.42 | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 8.14 | 7.76 | 7.90 | 7.79 | 8.58 | 8.12 | 7.68 | 7.43 | 7.16 | 6.92 | 6.80 | 6.47 | 6.08 | 5.63 | 5.21 | NA | NA | 3.95 | NA | |
| Property Plant And Equipment Net | 6.76 | 7.13 | 7.29 | 7.57 | 7.64 | 7.40 | 7.42 | 6.34 | 3.03 | 3.11 | 3.32 | 3.65 | 4.01 | 3.32 | 3.58 | NA | NA | 4.46 | NA | |
| Other Assets Noncurrent | 5.23 | 2.72 | 3.21 | 3.29 | 3.36 | 1.53 | 1.31 | 1.31 | 0.93 | 0.54 | 0.58 | 0.58 | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 55.02 | 42.77 | 30.27 | 48.24 | 39.38 | 44.55 | 45.27 | 46.15 | 46.99 | 51.25 | 48.69 | 44.17 | 37.65 | 43.85 | 40.01 | NA | NA | 33.64 | NA | |
| Accounts Payable Current | 1.63 | 1.45 | 1.28 | 2.25 | 1.03 | 1.17 | 2.37 | 4.45 | 3.40 | 4.51 | 3.75 | 4.47 | 3.74 | 5.68 | 5.26 | NA | NA | 5.38 | NA | |
| Other Liabilities Current | 2.14 | 2.04 | 2.11 | 1.46 | 1.26 | 2.05 | 1.21 | 1.28 | 0.31 | 0.41 | 0.20 | 0.24 | 0.89 | 0.47 | 0.16 | NA | NA | 0.28 | NA | |
| Contract With Customer Liability Current | 35.14 | 15.47 | 8.42 | 13.97 | 14.94 | 16.62 | 18.13 | 22.17 | NA | 31.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | 64.36 | 65.76 | 67.09 | 68.42 | 69.72 | 70.97 | 72.18 | 73.37 | 74.75 | 30.78 | 10.92 | 11.23 | 11.53 | 11.83 | 12.10 | NA | NA | 12.87 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 258.28 | 246.11 | 216.02 | 233.71 | 262.47 | 289.23 | 318.18 | 344.59 | 364.53 | 389.61 | 398.78 | 416.43 | 263.70 | 280.79 | -155.92 | -135.06 | -124.53 | -111.96 | -102.67 | |
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | NA | NA | 0.00 | NA | |
| Additional Paid In Capital Common Stock | 815.40 | 774.62 | 710.55 | 702.07 | 695.61 | 689.26 | 682.29 | 675.92 | 667.51 | 658.09 | 650.99 | 643.87 | 468.59 | 464.60 | 6.09 | NA | NA | 5.52 | NA | |
| Retained Earnings Accumulated Deficit | -556.74 | -528.38 | -493.63 | -466.59 | -430.67 | -395.89 | -358.70 | -326.75 | -299.33 | -267.71 | -252.06 | -227.37 | -204.79 | -183.82 | -162.03 | NA | NA | -117.49 | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0.38 | -0.13 | -0.90 | -1.77 | -2.47 | -4.14 | -5.41 | -4.58 | -3.65 | -0.78 | -0.15 | -0.07 | -0.09 | 0.01 | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 6.21 | NA | 8.20 | 6.42 | 6.25 | NA | 5.98 | 8.11 | 8.88 | NA | 6.03 | 5.17 | 3.85 | 2.72 | 0.44 | 0.16 | 0.12 | 0.73 | 0.63 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -18.12 | -24.01 | -30.71 | -19.00 | -33.12 | -29.13 | -28.02 | -22.20 | -26.60 | -25.67 | -18.36 | -18.00 | -24.93 | -21.54 | -14.45 | -14.59 | -16.67 | -10.30 | NA | |
| Net Cash Provided By Used In Investing Activities | -53.40 | 31.95 | 57.73 | 15.15 | 53.53 | 9.28 | 19.91 | 33.23 | -4.00 | -59.41 | -100.63 | 32.43 | -61.73 | -54.22 | -32.27 | -103.83 | -0.18 | -0.20 | NA | |
| Net Cash Provided By Used In Financing Activities | 34.58 | 57.67 | -10.75 | -0.75 | -0.68 | 0.05 | 0.36 | 0.26 | 0.48 | 0.47 | 0.58 | 170.50 | -0.15 | 194.05 | 2.50 | 152.22 | 0.16 | 0.08 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -18.12 | -24.01 | -30.71 | -19.00 | -33.12 | -29.13 | -28.02 | -22.20 | -26.60 | -25.67 | -18.36 | -18.00 | -24.93 | -21.54 | -14.45 | -14.59 | -16.67 | -10.30 | NA | |
| Net Income Loss | -28.36 | -34.75 | -27.04 | -35.92 | -34.78 | -37.19 | -31.96 | -27.41 | -31.62 | -15.66 | -24.68 | -22.58 | -20.97 | -21.80 | -21.84 | -10.79 | -11.91 | -10.02 | -10.09 | |
| Profit Loss | -28.36 | NA | -27.04 | -35.92 | -34.78 | NA | -31.96 | -27.41 | -31.62 | -15.66 | -24.68 | -22.58 | -20.97 | -21.80 | -21.84 | -10.79 | -11.91 | -10.02 | NA | |
| Increase Decrease In Accounts Receivable | 1.80 | 11.30 | -0.53 | 0.50 | -0.94 | -0.01 | -0.22 | -0.06 | -3.94 | 0.87 | -1.37 | 2.56 | -0.83 | 0.34 | -4.41 | 5.23 | -1.30 | 2.03 | NA | |
| Increase Decrease In Accounts Payable | 0.18 | 0.17 | -0.84 | 1.08 | -0.14 | -1.08 | -1.69 | 0.59 | -1.15 | 0.76 | -0.60 | 0.63 | -1.97 | 0.60 | -0.59 | 2.56 | -2.10 | 1.16 | NA | |
| Share Based Compensation | 6.21 | 6.36 | 8.20 | 6.42 | 6.25 | 6.92 | 6.01 | 8.15 | 8.94 | 6.35 | 6.09 | 5.23 | 3.85 | 2.72 | 0.44 | 0.16 | 0.12 | 0.73 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -53.40 | 31.95 | 57.73 | 15.15 | 53.53 | 9.28 | 19.91 | 33.23 | -4.00 | -59.41 | -100.63 | 32.43 | -61.73 | -54.22 | -32.27 | -103.83 | -0.18 | -0.20 | NA | |
| Payments To Acquire Property Plant And Equipment | NA | 0.16 | 0.60 | 0.36 | 0.59 | 1.49 | 3.31 | 0.53 | 0.17 | 0.11 | 0.00 | 0.75 | 0.42 | 0.29 | 0.28 | -0.11 | 0.18 | -0.07 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 34.58 | 57.67 | -10.75 | -0.75 | -0.68 | 0.05 | 0.36 | 0.26 | 0.48 | 0.47 | 0.58 | 170.50 | -0.15 | 194.05 | 2.50 | 152.22 | 0.16 | 0.08 | NA | |
| Payments For Repurchase Of Common Stock | 0.11 | 0.00 | 0.02 | 0.00 | 0.09 | NA | NA | NA | NA | NA | NA | NA | NA | -0.02 | 0.09 | NA | NA | -0.01 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3.04 | 3.26 | 11.07 | 2.66 | 3.76 | 2.85 | 6.75 | 13.83 | 7.65 | 20.08 | 8.50 | 9.78 | 7.43 | 8.26 | 8.45 | 9.67 | 6.82 | 8.21 | 5.36 | |
| Biogen Agreement | 0.85 | 2.93 | 2.85 | 2.50 | 2.34 | 0.86 | 4.10 | 9.53 | 4.72 | 6.07 | 4.83 | 2.94 | 1.88 | 3.09 | 3.52 | 2.31 | 1.00 | NA | NA | |
| Calico Agreement | NA | 0.00 | 0.00 | 0.00 | 1.07 | 1.60 | 1.78 | 1.75 | 1.81 | 2.04 | 1.34 | 3.95 | 3.35 | 3.55 | 3.53 | 3.60 | 3.55 | NA | NA | |
| M K D G Agreement | 0.06 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Merck Agreement | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Roche Agreement | 1.49 | 0.33 | 8.22 | 0.16 | 0.35 | 0.39 | 0.88 | 2.55 | 1.12 | 11.96 | 2.33 | 2.89 | 2.19 | 1.63 | 1.40 | 3.76 | 2.27 | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 3.04 | 3.26 | 11.07 | 2.66 | 3.76 | 2.85 | 6.75 | 13.83 | 7.65 | 20.08 | 8.50 | 9.78 | 7.43 | 8.26 | 8.45 | 9.67 | 6.82 | 8.21 | 5.36 | |
| Biogen Agreement | 0.85 | 2.93 | 2.85 | 2.50 | 2.34 | 0.86 | 4.10 | 9.53 | 4.72 | 6.07 | 4.83 | 2.94 | 1.88 | 3.09 | 3.52 | 2.31 | 1.00 | NA | NA | |
| Calico Agreement | NA | 0.00 | 0.00 | 0.00 | 1.07 | 1.60 | 1.78 | 1.75 | 1.81 | 2.04 | 1.34 | 3.95 | 3.35 | 3.55 | 3.53 | 3.60 | 3.55 | NA | NA | |
| M K D G Agreement | 0.06 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Merck Agreement | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Roche Agreement | 1.49 | 0.33 | 8.22 | 0.16 | 0.35 | 0.39 | 0.88 | 2.55 | 1.12 | 11.96 | 2.33 | 2.89 | 2.19 | 1.63 | 1.40 | 3.76 | 2.27 | NA | NA |
